IGF2BP3通过上调KLK4促进骨髓中介细胞干细胞的骨质分化
Jiazhu Tang1, Guoyang Zhao1, Jianzhong Zhao1
1Department of joint surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China.
Connective tissue research
|February 24, 2025
概括
胰岛素样生长因子2 mRNA结合蛋白3 (IGF2BP3) 通过调节骨髓中介质干细胞 (BMSC) 中的Kallikrein 4 (KLK4) 来促进骨的形成. 这一发现为骨质疏松症 (OP) 提供了一个新的治疗点.
科学领域:
- 骨生物学 骨生物学 骨生物学
- 干细胞分化的过程
- 分子机制的分子机制
背景情况:
- 骨质疏松症 (OP) 是一种代谢性骨病,其特征是骨质细胞和骨质细胞活性不平衡.
- 了解骨髓介质干细胞 (BMSCs) 骨质分化的分子途径对于开发新型OP治疗至关重要.
研究的目的:
- 调查BMSCs骨质生成差异化的分子机制.
- 为了确定骨质疏松症的潜在治疗点.
主要方法:
- 使用RT-qPCR对卡利克林4 (KLK4) 和胰岛素样生长因子2 mRNA结合蛋白3 (IGF2BP3) 的基因表达分析.
- 通过西布洛特的蛋白质表达分析.
- 使用性酸酶 (ALP) 和阿利沙林红色染色 (ARS) 评估BMSC骨质分化.
- 使用RNA免疫沉 (RIP) 和阿克丁诺米辛D测定对IGF2BP3和KLK4相互作用的研究.
主要成果:
- 在OP患者中,KLK4的表达量下降,在BMSC骨质分化过程中增加.
- 过度表达KLK4促进了BMSC骨质性分化.
- IGF2BP3增强了KLK4的表达,KLK4的上调调节挽救了IGF2BP3敲击的效果.
- 通过对KLK4.4进行上调调节,IGF2BP3促进了BMSC骨质生分化.
结论:
- 通过KLK4.4的介导,IGF2BP3促进了BMSC的骨质分化.
- 这种IGF2BP3-KLK4通路代表了骨质疏松症治疗的潜在治疗标.
相关概念视频
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


